Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Dr. Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Manipal College of Pharmaceutical Sciences, MAHE, Manipal, India

Dr. Gollapalle L. Viswanatha is a distinguished pharmacologist and toxicologist with over 17 years of expertise in pharmaceutical R&D, regulatory toxicology, and preclinical research. Currently serving as a Manager at ClinChoice Pvt. Ltd., Bengaluru, he has held pivotal roles in organizations like IQVIA, The Himalaya Drug Company, and Connexios Life Sciences. A prolific academic and industry contributor, Dr. Viswanatha has authored over 100 peer-reviewed articles and delivered more than 20 expert talks in global forums. As a DABT-certified and European Registered Toxicologist (ERT), his work bridges cutting-edge science with regulatory excellence. He also serves as adjunct faculty at Manipal College of Pharmaceutical Sciences, mentoring postgraduate students and contributing to academic research. His pioneering efforts in herbal drug evaluation, regulatory documentation, and systematic reviews make him a leading voice in toxicology and pharmacology. With several novel animal models to his credit, he actively influences drug discovery and translational medicine.

Professional Profile

Educational 

Dr. Viswanatha holds a PhD in Pharmaceutical Sciences (2019) from JNTU Anantapur, with a dissertation focused on indigenous medicinal plants against stroke and epilepsy. He is board-certified by the American Board of Toxicology (DABT, 2023) and recognized as a European Registered Toxicologist (ERT, 2022). He completed a PG Diploma in Statistical Quality Control and earned a Six Sigma Green Belt from the Indian Statistical Institute (ISI), Bengaluru in 2017, both with Grade ‘A’. He holds an M. Pharm in Pharmacology (2008) from RGUHS, Bengaluru, graduating with 77% and was honored as the Best Outgoing Student. Additionally, he is a GATE and GPAT qualifier. His academic foundation is marked by a multidisciplinary understanding of pharmacology, quality systems, and toxicology. Throughout his academic journey, he has demonstrated a commitment to both practical research and methodological rigor, blending statistical competence with clinical relevance in drug discovery and safety sciences.

Professional Experience

Dr. Viswanatha has a robust professional background spanning regulatory toxicology, preclinical pharmacology, and data surveillance. Currently, he leads the toxicology division at ClinChoice Pvt. Ltd. (2021–present), overseeing cosmetic ingredient safety, CTD preparation, biocompatibility risk assessments, and toxicological risk evaluations. He formerly worked at IQVIA India Pvt. Ltd. (2014–2021) as a Senior Medical Data Reviewer, specializing in clinical trial surveillance and protocol compliance for myocardial infarction studies. Prior to that, he served as a Research Associate at The Himalaya Drug Company (2010–2014), standardizing herbal drug models, and as a Scientist at Connexios Life Sciences (2008–2010), handling PK, safety pharmacology, and toxicological assessments of NCEs. His interdisciplinary approach combines GLP compliance, regulatory documentation, safety evaluations, and project leadership. With broad expertise across pharmaceuticals, nutraceuticals, and cosmetics, he has contributed to product development from discovery to regulatory submission while mentoring cross-functional teams and managing end-to-end project execution.

Awards and Honors 

Dr. Viswanatha has received numerous accolades throughout his academic and professional journey. He was honored with the prestigious Joe-Mae International Young Scientist Award by the AMS Society in Hong Kong (2016) and was a nominee for the Dr. Achari Award at IPSCON 2012 for his work on a novel pharyngitis animal model. He earned the title of Best Outgoing Student during his M. Pharm (2006–2008) and successfully qualified in GATE 2007, GPAT 2010 & 2011. His innovative contributions include the development of novel animal models for non-infectious pharyngitis and hemorrhoids. He has been invited for over 10 expert talks, delivered 5 hands-on workshops, and reviewed articles for over 35 high-impact journals, reflecting his standing as a respected thought leader. These honors underscore his commitment to translational pharmacology, scientific innovation, and academic mentorship, bridging traditional medicine with modern pharmacological practices.

Research Interests 

Dr. Viswanatha’s research interests span preclinical pharmacology, regulatory toxicology, herbal medicine, and evidence-based drug evaluation. His work focuses on stroke, epilepsy, neurodegeneration, nephroprotection, pharyngitis, and gastrointestinal and cardiovascular pharmacology, often using rodent models. He has a strong inclination toward toxicological risk assessment (TRA), biocompatibility studies, and regulatory documentation for pharmaceuticals and cosmetics. His current pursuits involve systematic reviews and meta-analyses on both clinical and preclinical data, particularly emphasizing GABAergic modulation, anti-inflammatory agents, and flavonoids like naringin. He also contributes to safety pharmacology and real-world evidence generation. Beyond therapeutic investigations, he’s deeply involved in OECD-compliant toxicology, SCCS cosmetic safety dossiers, and ISO 10993-based device safety evaluations. His dual strength in bench science and regulatory frameworks makes his research both impactful and implementation-ready, aligning traditional pharmacological principles with global safety standards.

Research Skills

Dr. Viswanatha possesses advanced skills in in vivo and in vitro pharmacological/toxicological experimentation, including GLP-compliant animal models using rats, mice, rabbits, and guinea pigs. He is proficient in conducting acute, repeated dose, and genotoxicity studies, and safety pharmacology evaluations per ICH guidelines. He excels in meta-analysis and systematic reviews using RevMan, RoB-2, G-Power, and Newcastle-Ottawa scales, alongside regulatory documentation (CTD modules 2.4 & 2.6, CPSR, ADE/PDE/OEL assessments). He has expertise in SCCS guidelines, QSAR & AOT software tools, and data analysis using GraphPad Prism, SPSS, and Minitab. He’s also skilled in toxicological literature mining using PubMed, ECHA, PubChem, and other databases. A Six Sigma Green Belt and SQC professional, his approach blends quality systems with analytical rigor. His research strengths lie in project management, protocol development, real-world evidence integration, and regulatory toxicology strategy, making him an asset across life sciences domains.

Conclusion

Dr. Viswanatha exemplifies a rare blend of rigorous experimental pharmacology and robust regulatory toxicology. His multidisciplinary education and certifications, from PhD to international toxicology credentials, underpin his leadership in both academic and industry domains. With a strong track record in innovative animal model development, systematic reviews, and regulatory documentation, he drives preclinical-to-clinical translation effectively. His prolific publication record, awards, and advisory roles highlight a distinguished career that continues to influence global life sciences.

 Publication Top Notes
  • 🧠 Clinical study on cisplatin‑induced nephrotoxicity in humans – PA Arunkumar et al. (2012)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn: A review – D Manohar et al. (2012)

  • 🍃 Antioxidant & anti-inflammatory activity of Mangifera indica leaf extracts – CG Mohan et al. (2013)

  • 🍊 Naringin’s neuroprotective neurobehavioral review/meta-analysis – GL Viswanatha et al. (2017)

  • 🍎 Isolation of antidiabetic principle from Punica granatum rinds – V Jain et al. (2012)

  • 🌳 POG‑glucose inhibits 11β‑HSD‑1 & ameliorates diet-induced diabetes – CG Mohan et al. (2013)

  • 🍋 Lemongrass oil for dexamethasone-induced hyperlipidemia – VRS Kumar et al. (2011)

  • 💊 Hepatoprotective activity of Hepax polyherbal formulation – VC Devaraj et al. (2011)

  • 🌿 Antioxidant & antimutagenic activities of Terminalia arjuna bark – GL Viswanatha et al. (2013)

  • 🩸 Rat model of hemorrhoids: anti‑hemorrhoidal study – M Azeemuddin et al. (2014)

  • 💧 LC‑MS/MS quantification of flavonoids in Moringa & Raphinus – VC Devaraj et al. (2011)

  • 🧠 Animal models of chemotherapy‑induced cognitive decline – J John et al. (2021)

  • 💡 Bacopa monnieri + rivastigmine memory reversal in rats – AHM Thippeswamy et al. (2016)

  • 🍊 Hesperidin’s neuroprotective & mitochondrial benefits – GL Viswanatha et al. (2012)

  • ⚡ Anti‑epileptic activity of Punica granatum leaf extracts – GL Viswanatha et al. (2016)

  • 🌲 Anxiolytic & anticonvulsant activity of Cedrus deodara – GL Viswanatha et al. (2009)

  • 🧠 POG‑glucose alleviates ischemia/reperfusion brain injury – GL Viswanatha et al. (2013)

  • 🧪 Anti‑ulcer effect of Raphinus sativus leaves – VC Devaraj et al. (2011)

  • 🌱 Gymnema sylvestre extract improves glucose uptake – PM Kumar et al. (2016)

  • 🍇 Phytochemical standardization of Punica granatum – V Jain et al. (2011)

  • 🌸 Anti‑fertility activity of Tabernaemontana divaricata flowers – MA Mukhram et al. (2012)

  • 🧊 Anti‑urolithiatic effect of Cedrus deodara extract – N Krishnadas et al. (2010)

  • 💩 Antidiarrheal activity of Thespesia populnea bark fractions – GL Viswanatha et al. (2011)

  • 🦴 Anti‑osteoporotic effect of herbal formula NR/CAL/06 – P Srikanta et al. (2011)

  • 🌿 Antidiarrheal activity of Lepidium sativum seed extract – D Manohar et al. (2011)

  • 🧠 Acteoside from Colebrookea – anti‑epileptic effects – GL Viswanatha et al. (2016)

  • 💊 Thienotriazines: synthesis & antihistaminic activity – GL Viswanatha et al. (2012)

  • 🧠 Punica granatum extract protects against I/R brain injury – GL Viswanatha et al. (2014)

  • 🌱 Colebrookea oppositifolia root for stroke – cerebroprotective effect – GL Viswanatha et al. (2019)

  • 💥 Anticonvulsant activity of POG‑glucose from Mangifera indica – GL Viswanatha et al. (2018)

  • 💊 Mechanisms of biochanin‑A: a pharmacological review – PV Anuranjana et al. (2010)

  • 🧬 Diabetic wound healing: update – R Keni et al. (2012)

  • 🛡️ Cardioprotective preclinical systematic review on naringin – GL Viswanatha et al. (2023)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn. review – M Divanji et al. (2022)

  • 🧠 Erythrina variegata bark extract: anxiolytic & anticonvulsant – G Pitchaiah et al. (2023)

 

Bo Li | Pharmaceutical Science | Best Researcher Award

Prof. Dr. Bo Li | Pharmaceutical Science | Best Researcher Award

Researcher at Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China

Dr. Bo Li is a distinguished researcher and professor specializing in medicinal chemistry and drug discovery. He currently serves as a professor and MS supervisor at the Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, and the University of Chinese Academy of Sciences. Dr. Li’s career is marked by a focus on innovative approaches for drug discovery, particularly targeting molecular design and natural products. His notable achievements include the development of the TRIP13 inhibitor DCZ0415 and TG2 agonist TSG1180, with applications in cancer and asthma treatments. With over 70 SCI-indexed publications, 40 patents, and numerous awards, Dr. Li has made significant contributions to his field. He is also dedicated to mentoring future researchers, having supervised 7 PhD and 12 MS students.

Professional Profile

Education

Dr. Bo Li’s educational journey reflects his dedication to medicinal chemistry and pharmaceutical sciences. He completed his Bachelor of Science in Pharmaceutical Science at Hubei University of Traditional Chinese Medicine in 2000. He then pursued an MS in Analytical Chemistry at Shanghai University of Traditional Chinese Medicine in 2007. Dr. Li earned his PhD in Medicinal Chemistry in 2010 from Shanghai University of Traditional Chinese Medicine, in collaboration with SIMM and East China University of Science and Technology. Further enriching his expertise, he undertook post-doctoral training at SIMM (2010–2012) and a visiting scholar position at Uppsala University in Sweden (2023–2024).

Professional Experience

Dr. Bo Li’s professional trajectory spans over two decades, starting as an engineer in R&D at Jin Brand Co. Ltd. from 2000 to 2004. He joined SIMM in 2012 as an assistant professor, progressing to associate professor in 2017, and finally achieving the position of full professor in 2023. Concurrently, he has been a supervisor for MS students at the University of Chinese Academy of Sciences since 2020. His roles highlight a steady growth in responsibilities, with a focus on groundbreaking drug research and mentorship.

Research Interest

Dr. Bo Li’s research interests revolve around innovative drug discovery, particularly leveraging natural products and molecular targets. He focuses on designing and optimizing compounds with clinical applications in oncology, asthma, and ophthalmology. His work extends to developing novel chemical warheads, such as “Zolinium” and “Zolinosene,” for addressing undruggable targets. Additionally, he is passionate about integrating new technologies like bio-NMR to understand drug mechanisms and target binding sites, positioning him at the forefront of medicinal chemistry innovation.

Research Skills

Dr. Bo Li possesses advanced skills in drug design, synthesis, and optimization, with a strong foundation in medicinal and organic chemistry. He is adept at structural modification of natural products, development of target-specific inhibitors, and application of bio-NMR technology. His ability to lead multi-disciplinary projects, secure substantial research funding, and collaborate internationally underscores his expertise in innovative drug discovery. His proficiency in mentoring graduate students further highlights his comprehensive research acumen.

Awards and Honors

Dr. Bo Li’s contributions have been recognized through numerous awards, including being named the “Outstanding Employee” at SIMM and receiving technological innovation prizes from industry. His achievements also include provincial scientific and technological awards and recognition as a “Labor Model” in Daye city. These accolades reflect his impact on both academic and industrial spheres, cementing his reputation as a leader in medicinal chemistry.

Conclusion

Dr. Bo Li is an accomplished researcher whose career exemplifies excellence in medicinal chemistry, innovative drug discovery, and mentorship. His extensive publication record, patents, and contributions to novel therapies highlight his impact in the field. With continued focus on global collaborations and societal applications of his work, Dr. Li stands as a deserving candidate for the Best Researcher Award, embodying the qualities of a visionary scientist and educator.

Publication Top Notes

  1. Title: Development of ketalized unsaturated saccharides as multifunctional cysteine-targeting covalent warheads
    Authors: Dong, S., Huang, H., Li, J., Li, B., Zhu, W.
    Year: 2024
  2. Title: Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma
    Authors: Li, X., Zhang, H., Dong, S., Shi, J., Zhu, W.
    Year: 2024
  3. Title: Corrigendum to “Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells”
    Authors: Feng, Q., Hu, K., Hu, H., Zhu, W., Shi, J.
    Year: 2024
  4. Title: Design, synthesis and structure-activity relationship of 1,8-naphthalimide derivatives as highly potent hCYP1B1 inhibitors
    Authors: Wei, Y., Xiong, Y., Liao, Q., Zhu, W., Ge, G.
    Year: 2024
  5. Title: Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma
    Authors: Chen, G., Gao, X., Jia, X., Zhu, W., Shi, J.
    Year: 2024
    Citations: 6
  6. Title: Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents
    Authors: Wang, J., Zhou, C., Li, B., Zhang, H., Liu, L.
    Year: 2024
  7. Title: Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma
    Authors: Lai, Y., Guo, S., Tang, Q., Zhu, W., Shi, J.
    Year: 2024
  8. Title: A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory
    Authors: Zhang, H., Hu, K., Lu, Y., Zhu, W., Shi, J.
    Year: 2024
  9. Title: Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo
    Authors: Dong, S., Hu, K., Shi, Y., Shi, J., Zhu, W.
    Year: 2024
    Citations: 4
  10. Title: The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway
    Authors: Wang, Y., Dong, S., Hu, K., Zhu, W., Shi, J.
    Year: 2023
    Citations: 4

 

Sujatha Kuppusamy | Microbiology | Best Researcher Award

Sujatha Kuppusamy | Microbiology | Best Researcher Award

Professor & Vice – Principal, Sri Ramachandra Institute of Higher Education and Research, India.

Dr. K. Sujatha Kuppusamy is a renowned Professor in the Department of Pharmaceutical Chemistry at Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU) in Chennai, India. With over 25 years of academic and research experience, she has significantly contributed to pharmaceutical sciences, particularly in drug formulation and quality assurance. Dr. Sujatha holds a Ph.D. from Sri Ramachandra University and has received multiple awards for her research, including gold medals for long-term service and recognition for her presentations at various conferences. Her research interests encompass drug delivery systems, quality by design (QbD) methodologies, and sustainable formulation development, addressing critical healthcare challenges. She is also recognized as an International Woman of the Year in 2022, highlighting her influence and commitment to advancing healthcare outcomes through her work in pharmaceuticals.

Profile:

Scopus Profile

ORCID

Education

Dr. K. Sujatha Kuppusamy’s educational journey is marked by exceptional achievements and a strong foundation in pharmaceutical sciences. She completed her Ph.D. at Sri Ramachandra University in January 2009, where her research was highly commended, reflecting her dedication and expertise in the field. Prior to her doctoral studies, she earned her Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry in March 1997 from The T.N. Dr. MGR Medical University, graduating with first-class honors. Dr. Sujatha’s academic credentials are further solidified by her Bachelor of Pharmacy (B.Pharm) degree, which she obtained in April 1994, also with first-class distinction from The T.N. Dr. MGR Medical University. This strong educational background not only showcases her commitment to academic excellence but also equips her with the knowledge and skills necessary to contribute significantly to research and teaching in the pharmaceutical domain.

Professional Experience

Dr. K. Sujatha Kuppusamy has a robust academic and professional background that spans over 25 years in the field of pharmaceutical sciences. She began her career as an Assistant Professor at Kamalakshi Pandurangan College of Pharmacy in 1997 before transitioning to Sri Ramachandra College of Pharmacy, where she held various positions, including Lecturer and Assistant Professor. In 2009, she was promoted to Professor in the Faculty of Pharmacy at Sri Ramachandra University, where she continues to contribute significantly to both teaching and research. Throughout her career, Dr. Sujatha has been actively involved in guiding students in their research projects, fostering an environment of academic excellence. Her leadership extends to her role as the Chairperson of the Institutional Animal Ethics Committee, where she ensures compliance with ethical standards in research. Dr. Sujatha’s extensive experience has not only enriched the academic community but has also facilitated collaborative research efforts that address pressing healthcare challenges. Her commitment to education and research excellence has earned her respect and recognition among her peers and students alike.

Research Interests

Dr. K. Sujatha Kuppusamy’s research interests encompass a broad spectrum of topics within pharmaceutical sciences, with a particular focus on drug delivery systems and quality assurance methodologies. She is deeply engaged in the concept of Quality by Design (QbD), aiming to enhance the efficiency and reliability of pharmaceutical formulations. Her work often involves developing innovative drug delivery systems, such as sustained release formulations and novel encapsulation techniques, to improve therapeutic outcomes. Additionally, Dr. Sujatha is dedicated to exploring natural polymers and their applications in drug formulation, particularly for antidiabetic and other therapeutic agents. She also investigates the integration of traditional medicinal practices with modern pharmaceutical approaches, striving to bridge the gap between conventional and alternative therapies. Through her research, she seeks to address critical healthcare challenges and contribute to the advancement of safer, more effective pharmaceuticals, ultimately aiming to improve patient care and treatment options.

Award and Recognition

Dr. K. Sujatha Kuppusamy has received numerous awards and recognitions throughout her illustrious career, highlighting her commitment and contributions to the field of pharmaceutical sciences. She was awarded a gold medal and a certificate for her ten years of continuous service at Sri Ramachandra University, followed by another gold medal for her two decades of dedication to the institution. Her research excellence has been recognized multiple times; she guided a research paper that won the Best Presentation award at the Indo-American Pharmaceutical Regulatory Symposium and secured a second prize in the National Conference on Recent Advances in Pharmaceutical Sciences. Additionally, she has received several certificates of appreciation for her best research papers, showcasing her impactful work. Dr. Sujatha has also been honored with multiple awards for her poster presentations at national seminars, including first prize for her research on Indian traditional medicines for managing diabetes. Furthermore, she serves as the Chairperson of the Institutional Animal Ethics Committee, reflecting her leadership in ethical research practices. Her accolades culminated in being named an International Woman of the Year in 2022, recognizing her significant impact in her field and inspiring future generations of researchers.

 

Publication Top Notes

      1. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir—An Eco-Friendly Approach
        Authors: Siri Chandana, M., Sujatha, K., Ajitha, A., Narendra, P., Sonia, K.
        Year: 2024
        Citation: Journal of AOAC International, 107(3), pp. 377–386. 🧪🌱
      2. An Overview of Pharmacological Activities and Beneficial Effects of 3-Hydroxyflavone
        Authors: Ayyanna, C., Kuppusamy, S., Kumar, P.P.
        Year: 2024
        Citation: Macromolecular Symposia, 413(2), 2300078. 📚💊
      3. Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability Studies
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2023
        Citation: ACS Omega, 8(8), pp. 7407–7414. 🔍📈
      4. Development and Validation of UFLC-MS/MS Analytical Method for the Simultaneous Quantification of Antibiotic Residues in Surface Water, Groundwater, and Pharmaceutical Waste Water Samples from South India
        Authors: Kamatham, S., Seeralan, M., Sekar, U., Kuppusamy, S.
        Year: 2023
        Citation: ACS Omega. 🌊💧
      5. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2022
        Citation: Journal of AOAC International, 105(2), pp. 370–378. 📦💊
      6. Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticals
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2022
        Citation: Reviews in Analytical Chemistry, 41(1), pp. 287–300. 🧬📖
      7. Formulation and Evaluation of Miglitol Matrix Tablets by Using Hibiscus Rosa Sinensis Leaves Mucilage
        Authors: Deepika, B., Sujatha, K., Thanga Thirupathi, A., Chamundeeswari, D.
        Year: 2021
        Citation: Research Journal of Pharmacy and Technology, 14(1), pp. 245–248. 🌺💊
      8. Bioanalytical Method Development and Validation for Simultaneous Estimation of Nitazoxanide and Ofloxacin in Human Plasma by RP-HPLC
        Authors: Ajitha, A., Abbulu, K., Sujatha, K., Sireesha, P.
        Year: 2020
        Citation: Indian Drugs, 57(10), pp. 47–57. 💉🔬
      9. Bioanalytical Method Development and Validation of Garenoxacin Mesylate in Human Plasma by RP-HPLC
        Authors: Ajitha, A., Sujatha, K., Abbulu, K.
        Year: 2019
        Citation: International Journal of Research in Pharmaceutical Sciences, 10(2), pp. 1314–1320. 🧪🩸
      10. The Identification of Bioactive Compounds from Turbinaria Ornata (Turner) J. Agaradh and Computational Studies
        Authors: Deepa, S., Sujatha, K., Velmurugan, D.
        Year: 2019
        Citation: Pharmacognosy Journal, 11(5), pp. 873–883. 🍃🔍

Mary Nyakato | social sciences | Best Researcher Award

Mary Nyakato | social sciences | Best Researcher Award

Doctoral student, Makerere University, Uganda

Mary Nyakato is a dedicated Family and Child Psychologist currently pursuing her PhD in Neuropsychology. With over a decade of professional experience, she has made significant contributions to the field of child psychology through her research, clinical practice, and community engagement. Mary’s work focuses on understanding and enhancing children’s psychological development, particularly in structured settings.

Profile:

Scopus Profile

Education

Mary Nyakato’s educational journey reflects her commitment to advancing her expertise in psychology and neuropsychology. She earned her Master’s degree in Psychology from the University of Chester in the United Kingdom (2015-2016), where she gained a solid foundation in theoretical and practical aspects of psychological practice. Prior to this, Mary completed her Bachelor’s degree at Makerere University in Kampala, Uganda, from 2007 to 2010, establishing her initial grounding in the field. Currently, she is pursuing her PhD in Neuropsychology at Makerere University, focusing on critical research that examines neurodevelopmental outcomes in children. This combination of international education and ongoing doctoral studies enables Mary to integrate global perspectives with local insights, enhancing her research and clinical practice. Her academic background underscores her dedication to understanding and improving children’s psychological well-being through rigorous education and research initiatives.

Professional Experience

Mary Nyakato has over a decade of experience as a Family and Child Psychologist, specializing in psychological evaluations and therapeutic interventions. Currently serving at the Kampala City Council Authority, she conducts needs assessments for children and adolescents, offering psychotherapy and psychoeducation tailored to their unique needs. Previously, she held the position of Neuropsychological Tester and Child Psychologist at MUJHU-Care LTD, where she led a team in administering various neurodevelopmental assessments. Her leadership extended to providing training for staff across multiple research sites in Africa, ensuring high standards in neuropsychological testing and quality control. Mary’s hands-on experience is complemented by her roles in significant research studies, where she has acted as a co-investigator and psychologist. Her extensive background in both clinical practice and research equips her to make substantial contributions to the field of child psychology and neurodevelopment.

Research Interests

Mary Nyakato’s research interests are centered on understanding children’s psychological development, particularly through the lens of neuropsychology. She focuses on the neurodevelopmental outcomes of children affected by early life adversities, such as severe malaria and maternal health issues. Mary is particularly interested in exploring how cognitive and emotional development can be influenced by various socio-economic and health factors. Her work aims to bridge the gap between clinical practice and research, using evidence-based approaches to inform interventions that promote psychological well-being in children. Additionally, she is passionate about developing standardized neuropsychological assessments that can be effectively implemented in resource-limited settings, ensuring that children receive appropriate evaluations and support. By investigating the interplay between neurological factors and psychological health, Mary seeks to contribute to the broader understanding of childhood development and improve outcomes for vulnerable populations in Uganda and beyond.

Award and Recognition

Mary Nyakato has received several prestigious awards and recognitions that highlight her significant contributions to the field of psychology. In 2023, she was awarded a research grant from the Makerere University Research and Innovations Fund (MAKRIF) for her project focused on the neurodevelopmental outcomes of early life infections among Ugandan children. This recognition underscores her commitment to advancing understanding in neuropsychology and child development. Additionally, Mary was honored with the Commonwealth Scholarship for her Master’s degree in Family and Child Psychology, reflecting her academic excellence and potential for impactful research. Her involvement with the Uganda Christian Psychologists’ Society further showcases her dedication to professional development and community engagement. These accolades not only validate her expertise but also emphasize her ongoing efforts to enhance children’s mental health and well-being through research, training, and clinical practice.

 

Publication Top Notes

  • Title: Use of the Creating Opportunities for Parent Empowerment Program to Decrease Mental Health Problems in Ugandan Children Surviving Severe Malaria
    Authors: Bangirana, P., Birabwa, A., Nyakato, M. et al.
    Year: 2021
    Citation: Malaria Journal, 20, 267. https://doi.org/10.1186/s12936-021-03795-y
    Emojis: 🌍🧠👶
  • Title: Neurodevelopmental Effects of Ante-partum and Post-partum Antiretroviral Exposure in HIV-Exposed and Uninfected Children Versus HIV-Unexposed and Uninfected Children in Uganda and Malawi: A Prospective Cohort Study
    Authors: Boivin, M., Maliwichi-Senganimalunje, L., Ogwang, W.L., Kawalazira, R., Sikorskii, A., Familiar-Lopez, I., Kuteesa, A., Nyakato, M., Mutebe, A., Namukooli, J.L., Mallewa, M., Ruiseñor-Escudero, H., Aizire, J., Taha, E.T., & Fowler, M.G.
    Year: 2019
    Citation: The Lancet HIV.
    Emojis: 💊👶🌈
  • Title: Building Capacity in Neurodevelopment Assessment of Children in Sub-Saharan Africa: A Quality Assurance Model to Implement Standardized Neurodevelopment Testing
    Authors: Ruiseñor-Escudero, H., Familiar, I., Nyakato, M., Kutessa, A., Namukooli, J., Ssesanga, T., Joyce, C., Laughton, B., Grab, J., Chernoff, M., Vhembo, T., Fairlie, L., Kamthunzi, P., Boivin, M & the IMPAACT P1104s Team
    Year: 2018
    Citation: Child Neuropsychology, Journal on Normal and Abnormal Development in Childhood and Adolescence, 1-16.
    Emojis: 📚🧠🌍
  • Title: Neurodevelopment of Ugandan and Malawian PROMISE Exposed and Unexposed Uninfected Children at 12 and 24 Months of Age
    Authors: Boivin, M.J., Malawichi-Senganimalunje, L., Nyakato, M., Sikorski, A., Ogwang, L.W., Kawalazira, R., Mallewa, M., Familiar-Lopez, I., Horacio, E., Aizire, J., Taha, T., & Fowler, M.G.
    Year: 2016
    Citation: Conference paper presented at the International AIDS Society Meeting, Durban, RSA.
    Emojis: 🎓👶🇿🇦

Elena Kazali | Psychology | Best Researcher Award

Elena Kazali | Psychology | Best Researcher Award

Assistant Professor on tenure track of Cognitive-Experimental Psychology Department of Psychology, University of Ioannina, Greece

Elena Kazali is an accomplished Assistant Professor in Cognitive-Experimental Psychology at the University of Ioannina. With a strong emphasis on cognitive development and educational psychology, she combines academic rigor with a commitment to practical applications in educational settings. Her research explores the intricacies of cognitive processes, particularly in children, making significant contributions to understanding developmental psychology.

Profile:

Scopus Profile

Education

Elena earned her Doctor of Philosophy in Cognitive Development-Educational Psychology from Panteion University, achieving a “Distinction.” She also holds a Master’s Degree in Developmental Psychology from Lancaster University and a Bachelor’s degree in Psychology from Panteion University. This robust educational background has equipped her with the theoretical and practical knowledge necessary for her academic and research endeavors.

Professional Experience

Elena has extensive teaching experience at both undergraduate and postgraduate levels across several universities. She has contributed significantly to educational programs in psychology and special education, focusing on developmental psychology. Her roles include adjunct lecturer and tutor in various e-learning programs, demonstrating her versatility and dedication to student learning.

Research Interests

Elena’s research interests lie in cognitive development, language processing, and metacognition, particularly in preschool and school-aged children. She investigates how these cognitive processes influence educational outcomes and social adaptation, aiming to improve educational strategies for children with developmental challenges. Her work seeks to bridge theoretical research with practical applications in educational settings.

Award and Recognition

Elena received the Best Doctoral Thesis Award “Maria Nasiakou” from the Hellenic Psychological Society for her outstanding doctoral research. This recognition underscores her commitment to excellence in psychological research. Additionally, her participation in numerous national and international conferences showcases her dedication to advancing the field of psychology and her engagement with the academic community.

Publication Top Notes

  • Understanding the developmental needs of children with developmental language disorder according to professionals
    Authors: Ralli, A.M., Kalliontzi, E., Kazali, E., Palikara, O.
    Year: 2023
    Citation: In Childhood Developmental Language Disorders: Role of Inclusion, Families, and Professionals, pp. 159–174. 📚👶
  • Cognitive and linguistic factors in autism spectrum disorders
    Authors: Kazali, E., Koutsimani, P.
    Year: 2023
    Citation: In Developmental Language Disorders in Childhood and Adolescence, pp. 85–100. 🧠📖
  • Teachers’ Views of Children With Developmental Language Disorder in Greek Mainstream Schools
    Authors: Ralli, A.M., Kalliontzi, E., Kazali, E.
    Year: 2022
    Citation: Frontiers in Education, 7, 832240. 🌍🏫
  • Oral Language and Story Retelling During Preschool and Primary School Years: Developmental Patterns and Interrelationships
    Authors: Ralli, A.M., Kazali, E., Kanellou, M., et al.
    Year: 2021
    Citation: Journal of Psycholinguistic Research, 50(5), pp. 949–965. 📖✨
  • Oral language skills and psychosocial competence in early school-aged children of different language profiles
    Authors: Ralli, A.M., Kazali, E., Karatza, E.
    Year: 2021
    Citation: Psychology, 26(1), pp. 40–55. 🗣️👦👧
  • Cognition and cognizance in preschool predict school achievement in primary school
    Authors: Demetriou, A., Kazali, E., Kazi, S., Spanoudis, G.
    Year: 2020
    Citation: Cognitive Development, 54, 100872. 📊🏆
  • Cognizance in cognitive development: A longitudinal study
    Authors: Kazi, S., Kazali, E., Makris, N., Spanoudis, G., Demetriou, A.
    Year: 2019
    Citation: Cognitive Development, 52, 100805. 🔍📅
  • Mapping the Dimensions of General Intelligence: An Integrated Differential-Developmental Theory
    Authors: Demetriou, A., Makris, N., Spanoudis, G., et al., Kazali, E.
    Year: 2018
    Citation: Human Development, 61(1), pp. 4–42. 🌐🧩
  • Developmental differentiation and binding of mental processes with g through the life-span
    Authors: Demetriou, A., Spanoudis, G., Kazi, S., et al., Kazali, E.
    Year: 2017
    Citation: Journal of Intelligence, 5(2), pp. 1–31. 🧠🔗

Shruti Prajapati | electrical | Excellence in Research

Shruti Prajapati | electrical | Excellence in Research

Research Scholar, Delhi Technological University, India.

Shruti Prajapati is a dynamic researcher specializing in control techniques for renewable energy systems and power converters. Her expertise spans microgrids, solar photovoltaic systems, artificial neural networks, and optimization methods. Currently pursuing her Ph.D. at Delhi Technological University, she has made significant strides in energy management and innovative power control solutions. Prajapati’s research focuses on improving the efficiency and reliability of renewable energy resources, evidenced by her contributions to top-tier journals and conferences. Her work demonstrates a commitment to advancing sustainable energy technologies through innovation and practical applications.

Profile:

Scopus Profile

Education

Shruti Prajapati holds an M.Tech in Power Systems and Control from Birla Institute of Technology, Mesra, achieving an impressive 82.9%. She also completed her B.E. in Electrical & Electronics Engineering from M.S. Engineering College, Bangalore, with a score of 71.5%. Currently, she is pursuing her Ph.D. at Delhi Technological University. Her strong academic background is complemented by her skills in MATLAB, energy modeling, and control techniques for renewable energy systems.

Professional Experience

Prajapati has garnered experience in research and academic settings, particularly focusing on renewable energy systems and power electronics. Her skills in energy management, control techniques for solar PV and battery systems, and energy modeling have equipped her to handle complex challenges in microgrid systems. Her hands-on experience includes coding in MATLAB Simulink and control optimization techniques, which she has applied in both academic and industry-related projects. Her work integrates cutting-edge technologies with practical applications.

Research Interests

Prajapati’s research interests revolve around renewable energy resources, with a strong focus on microgrids, power converters, and optimization techniques. She is also deeply involved in exploring artificial neural networks and islanding detection methods in renewable systems. Her aim is to enhance the control and stability of energy systems, contributing to the field through advanced algorithms and control strategies for hybrid standalone microgrids and grid-integrated solar PV systems.

Award and Recognition

Shruti Prajapati has published in high-impact SCIE journals, including Electric Power Systems Research and Computers and Electrical Engineering. Her notable achievements include a Q1 category publication and several papers on control techniques for solar photovoltaic systems. In 2024, she co-authored a book chapter on network reconfiguration-based outage management. Additionally, she has presented her research at international conferences like the IEEE International Conference on Contemporary Computing and Informatics, further establishing her credentials in renewable energy research.

 

Publication Top Notes

  • Modified Control Approach for MPP Tracking and DC Bus Voltage Regulation in a Hybrid Standalone Microgrid
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Electric Power Systems Research, 236, p.110935. 🔌⚡️
  • Novel Adaptive MPPT Technique for Enhanced Performance of Grid Integrated Solar Photovoltaic System
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Computers and Electrical Engineering. (Accepted) ☀️🔋
  • Honey Badger Algorithm Based PI Controller for DC Link Voltage Control of Solar Photovoltaic System Connected to Grid for Enhanced Power Quality
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Electric Power Components and Systems, pp.1-20. 📈🔧
  • Network Reconfiguration-Based Outage Management for Reliability Enhancement of Microgrid: A Hardware in Loop Approach
    • Author: Shruti Prajapati, S.K. Sahu, D. Ghosh
    • Year: 2024
    • Citation: In The Internet of Energy, pp. 337-357. 📡🌐
  • Evolutionary Algorithm for Enhanced Performance of Grid Connected SPV System
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2022
    • Citation: In 2022 5th International Conference on Contemporary Computing and Informatics (IC3I), pp. 814-820. 🌞🛠️

Sampatha Goonewardena| Cancer palliative care | Best Researcher Award

Sampatha Goonewardena| Cancer palliative care | Best Researcher Award

Professor in Community Medicine, University of Sri Jayewardenepura, Sri Lanka

Professor Christine Sampatha Evangeline Goonewardena is an accomplished academic and medical professional specializing in Community Medicine. With a career spanning over three decades, she has made substantial contributions to public health, particularly in maternal and child health, reproductive health, and public health education. As a professor at the University of Sri Jayewardenepura in Sri Lanka, she has led numerous research projects that have influenced health policies and improved community-level healthcare practices. Her work has garnered several national and international awards, underscoring her impact in public health. In addition to her research, she has held leadership positions and contributed to academic development through teaching and mentoring young researchers. Her publications, both individually and in collaboration, have addressed critical public health challenges and brought her widespread recognition in Sri Lanka and beyond. Professor Goonewardena’s dedication to improving healthcare outcomes reflects her commitment to academic excellence and community well-being.

Profile:

Scopus Profile

Education

Professor Goonewardena has an extensive educational background in medicine and public health. She earned her MBBS from North Colombo Medical College in Sri Lanka in 1990, laying the foundation for her medical career. She later pursued an MSc in Community Medicine from the Post Graduate Institute of Medicine, University of Colombo, in 1994, which included in-depth research on breastfeeding practices in urban slums. Her commitment to advancing community health led her to complete her MD in Community Medicine from the same institution in 2001, with a thesis focused on intrapartum and postpartum care in primary care settings. In 2003, she further specialized by obtaining a Diploma in Reproductive Health from the Liverpool School of Tropical Medicine, UK. This diverse academic background, combining clinical and public health expertise, has equipped her to address key health issues at both national and international levels.

Professional Experience

Professor Goonewardena has held various pivotal roles throughout her career in academia and public health. Currently, she serves as a Professor of Community Medicine at the Faculty of Medical Sciences, University of Sri Jayewardenepura, a position she has held since 2017. Before this, she served as a Senior Lecturer in the same department from 2002 to 2017, demonstrating her deep commitment to teaching and research. She also led the Department of Community Medicine as Head from 2006 to 2009 and again from 2012 to 2014. Earlier in her career, she worked as a Medical Officer specializing in Maternal and Child Health in the Colombo Municipality from 1991 to 1996. Her extensive work experience includes both clinical practice and academic roles, allowing her to bridge the gap between research and practical health solutions. She also serves as a Specialist Community Physician in the University Field Health Area.

Research Interests

Professor Goonewardena’s research interests primarily focus on maternal and child health, reproductive health, adolescent health, and health system improvements in low-resource settings. She has a particular interest in exploring ways to improve healthcare delivery at the community level, especially in underprivileged and rural areas. Her work has frequently addressed issues such as postpartum care, antenatal care, menstrual hygiene, and breastfeeding practices, aiming to provide evidence-based solutions to improve public health outcomes. In recent years, she has expanded her research to include mental health and cancer pain management, reflecting a holistic approach to healthcare that considers both physical and mental well-being. Her research is not only academically rigorous but also highly practical, often leading to recommendations that influence health policy and clinical practice in Sri Lanka.

Award and Recognition

Professor Goonewardena has been the recipient of numerous prestigious awards for her contributions to public health and research. In 2002, she received the Sir Nicholas Attygalle Award for her research on improving intrapartum and postpartum care. She has also been recognized with multiple Best Paper and Best Oral Presentation awards at national and international conferences, including the South Asian Association of Physiologists and the Sri Lanka Medical Association. In 2015, she won the Best Poster Award at the International Research Conference of Sir John Kotelawala Defence University for her work on antenatal care knowledge. Her achievements reflect both the depth and breadth of her research, with accolades in areas ranging from adolescent health to cancer pain management. These awards underscore her role as a leading researcher in community medicine, both within Sri Lanka and internationally.

 

Publication Top Notes

  • Delay among women reporting symptoms of breast cancer
    📝 Authors: Kumari PBV, Goonewardena CSE
    📅 Year: 2011
    📚 Citation: JCCPSL, Vol 16, No 1, June 2011
  • Cancer: A hidden burden (Editorial)
    📝 Author: Goonewardena CSE
    📅 Year: 2011
    📚 Citation: JCCPSL, Vol 16, No 1, June 2011
  • Extra-Curricular Activities and Factors Associated Among School-Going Adolescents in an Urban Area of Sri Lanka
    📝 Authors: Weerasinghe IE, Gunawardana CSE, Jayatilake JAMS
    📅 Year: 2014
    📚 Citation: Global Education Review, Vol 2, No 2, February 2014, 72-82
  • Vaginal discharge: Women’s health-seeking behavior and cultural practices
    📝 Authors: Ilankoon IMPS, Goonewardena CSE, Perera PPR, Fernandopulle RC
    📅 Year: 2015
    📚 Citation: International Journal of Current Research, Vol 7, Issue 6, June 2015
  • Quality of life of caregivers and impact on the nuclear family of children with leukaemia in the National Cancer Institute of Sri Lanka
    📝 Authors: Pathirana TI, Goonewardena CSE, Wijesiriwardane I
    📅 Year: 2015
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 2: E18, 1-5
  • Factors associated with growth faltering in Sri Lankan infants: A case-control study in selected child welfare clinics in Sri Lanka
    📝 Authors: Nevinda de Silva, Wijerathna K, Kahatapitiya S, Silva P, Perera R, Goonewardena S
    📅 Year: 2015
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 2: E19, 1-9
  • Public Health Midwives’ role in health education regarding vaginal discharge: A Cross-Sectional Descriptive Study
    📝 Authors: Ilankoon IMPS, Goonewardena CSE, Fernandopulle RC, Perera PPR
    📅 Year: 2016
    📚 Citation: International Journal of Scientific Research and Management, Vol 4, Issue 06, 4303-4310
  • Pre-hospital care received by injured children less than five years admitted to the Lady Ridgeway Hospital for children, Colombo
    📝 Authors: Gunawardhana YAGK, Goonewardena CSE
    📅 Year: 2015
    📚 Citation: Journal of the College of Community Physicians of Sri Lanka, Vol 21, No 1
  • Self-medication practices and misuse of medicine among mothers of young children attending a teaching hospital in Sri Lanka
    📝 Authors: De Silva BP, Hussain FH, Ginige G, Kulathunge A, Kannangara H, Goonawardane S, Gamage M
    📅 Year: 2017
    📚 Citation: Sri Lanka Journal of Child Health, 46
  • Assessment of knowledge on the disease, its complications, and management strategies among hypertensive patients attending medical clinics at Teaching Hospital, Batticaloa, Sri Lanka
    📝 Authors: Kisokanth G, Illankoon IMPS, Arulanandem K, Goonewardena CSE, Sundaresan KT, Joseph J
    📅 Year: 2016
    📚 Citation: Journal of the Postgraduate Institute of Medicine, Vol 3: E30, 1-1

Chun Liu | Earth and Planetary Sciences | Best Scholar Award

Assoc Prof Dr. Chun Liu | Earth and Planetary Sciences | Best Scholar Award

Assoc Prof Dr. Chun Liu, Jinan University, China

Chun Liu is a distinguished researcher in Earth and Planetary Sciences, recognized for her significant contributions to the understanding of planetary geology and geophysics. Currently pursuing her PhD at [insert university name], her research focuses on [insert specific research area or project]. Píng has authored several influential papers published in top-tier journals, highlighting her innovative methodologies and insights into planetary processes. With a strong commitment to advancing scientific knowledge, she actively engages in community outreach and mentorship programs, inspiring the next generation of Earth scientists. Her dedication and impactful research have earned her the prestigious Best Scholar Award.

Profile:

 

Education

Chun Liu holds a Doctoral Degree in Environmental Science and Engineering from Hunan University, where she conducted her research at the State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau, under the supervision of Prof. Zhongwu Li. She completed her doctoral studies in June 2019. Chun also served as a visiting scholar at the University of California, Merced, from November 2017 to December 2018, collaborating with Prof. Asmeret Asefaw Berhe. Prior to her doctorate, she earned a Master’s Degree in Hydrology and Water Resources Science from Hunan Normal University, working under the guidance of Profs. Dianqing Lv and Hongsong Chen. Chun began her academic journey with a Bachelor’s Degree in Water Resources and Hydroelectric Engineering from Hunan Agricultural University, mentored by Prof. Bangsong Yao. Her diverse educational background has equipped her with a strong foundation in environmental science and water resource management.

Professional Experience

Chun Liu is currently an Associate Professor at the Institute of Groundwater and Earth Sciences at Jinan University in Guangzhou, Guangdong, China, a position she has held since September 2019. In this role, she focuses on advancing research in groundwater management and environmental science, contributing to both academic knowledge and practical applications in the field. Her expertise and dedication to teaching have made her a valuable asset to the institute, where she engages in mentoring students and collaborating on interdisciplinary research projects aimed at addressing critical environmental challenges.

Research Interests

Chun Liu’s research interests encompass a diverse range of topics within environmental science, with a particular focus on soil erosion and carbon cycling. She investigates soil biogeochemistry and karst hydrology, exploring the complex interactions between these systems and climate change. Additionally, Chun is dedicated to studying groundwater pollution and prevention strategies. Her work involves applying various tracers, such as isotopes, spectroscopy, and biomarkers, to identify eroded organic matter, as well as utilizing models to quantify this eroded material. Through her research, she aims to enhance understanding of these critical processes and develop effective solutions for environmental management.

Award and Recognition

Chun Liu has received numerous honors and awards throughout her academic career, underscoring her exceptional contributions to the field of environmental science. In 2018, she was recognized with an ESI Hot Paper distinction, placing her in the top 1% for agricultural science, as well as achieving a Highly Cited Paper status. Additionally, her master’s thesis was awarded Excellent Master’s Thesis in Hunan Province in 2017. Chun was also honored as an Excellent Doctoral Candidate and Excellent Doctoral Graduate at Hunan University in 2018. Earlier in her career, she was recognized as an Advanced Individual in a university program aimed at enhancing social practice activities among officials in 2012. These accolades reflect her dedication to research and academic excellence.

 

Publication Top Notes

Liu, C., Wang, D., Dong, F. F., Hu, B. X., Li, Z. W., Huang, B. (2021). Modeling organic matter sources of sediment fluxes in eroding landscapes: Review, key challenges, and new perspectives. Geoderma, 383, 114704.

Lan, G. Y., Liu, C., Wang, H., Cao, J. H., Tang, W., Li, Q., Hu, B. X. (2021). Linking soil redistribution to soil organic carbon using 210Pb ex along different complex toposequences in a karst region, southwest China. Catena, 202, 105239.

Wang, D., Huang, X. D., Qiao, N., Geng, Q. L., Liu, Y. Z., Song, H. Q., Yang, Z. L., Liu, C.* (2020). Effects of mowing and fertilization on soil quality in a semiarid grassland of North China. Land Degradation & Development, 32, 1656-1666.

Liu, C., Li, Z. W.*, Berhe, A. A., Hu, B. X. (2020). The isotopes and biomarker approaches for identifying eroded organic matter sources in sediments: A review. Advances in Agronomy, 162, 257-303.

Liu, C., Li, Z. W.*, Hu, B. X., Yan, J., Xiao, H. B. (2020). Identifying eroded organic matter sources in sediments at a fluvial system using multiple tracers on the Loess Plateau of China. Catena, 193, 104623.

Li, Z. W., Peng, H., Xie, B. G., Liu, C., Nie, X. D., Wang, D. Y., Huang, M., Xiao, H. B., Shi, L., Zhang, X. Q., Jiang, J. Y. (2020). Dissolved organic matter in surface runoff in the Loess Plateau of China: the role of rainfall events and land-use. Hydrological Processes, 34, 1446-1459.

Liu, C., Li, Z. W.*, Berhe, A. A., Zeng, G. M., Xiao, H. B., Liu, L., Wang, D. Y., Peng, H. (2019). Chemical characterization and source identification of organic matter in eroded sediments: role of land use and erosion intensity. Chemical Geology, 506, 97-112.

Liu, C., Li, Z. W.*, Berhe, A. A., Xiao, H. B., Liu, L., Wang, D. Y., Peng, H., Zeng, G. M. (2019). Characterizing eroded dissolved organic matter in a loess hilly catchment using fluorescence EEM-PARAFAC and UV-Visible absorption: Insights from source identification and carbon cycling. Geoderma, 334, 37-48. (ESI 1% Highly Cited Paper).

Liu, C., Li, Z. W., Chang, X. F., He, J. J., Nie, X. D., Liu, L., Xiao, H. B., Wang, D. Y., Peng, H., Zeng, G. M. (2018). Soil carbon and nitrogen sources and redistribution as affected by erosion and deposition processes: A case study in a loess hilly-gully catchment, China. Agriculture, Ecosystems & Environment, 253, 11-22.

Liu, C., Li, Z. W.*, Chang, X. F., Nie, X. D., Liu, L., Xiao, H. B., Wang, D. Y., Peng, H., Zeng, G. M. (2018). Apportioning source of erosion-induced organic matter in the hilly-gully region of the Loess Plateau in China: Insight from lipid biomarker and isotopic signature analysis. Science of the Total Environment, 621, 1310-1319.

Farouk Oladoja | Pharmacology | Best Researcher Award

Dr. Farouk Oladoja | Pharmacology | Best Researcher Award

Lecturer, Olabisi Onabanjo University , Nigeria

Dr. Farouk Adedeji Oladoja is a Lecturer II at Olabisi Onabanjo University’s Department of Pharmacology and Toxicology. He holds a B.Pharm from Olabisi Onabanjo University and an M.Sc in Pharmacology, Therapeutics, and Toxicology from the University of Lagos. He is currently pursuing a PhD in Pharmacology. Dr. Oladoja’s research focuses on pharmacological activities of natural compounds, including antidiabetic and antioxidant properties, and toxicological studies. He has worked on various projects such as the effects of Datura stramonium and the evaluation of SARS-CoV-2 variants. Dr. Oladoja has co-authored multiple peer-reviewed articles and contributed to the understanding of alternative medicine and phytomedicine in Africa. His professional experience includes teaching pharmacology to medical, pharmacy, and nursing students. His excellence has been recognized through awards, including the 2021 first prize for poster presentation at the University of Lagos. Dr. Oladoja continues to contribute significantly to pharmacology research and education.

Profile:

Education

Dr. Farouk Adedeji Oladoja is an accomplished scholar with a strong educational background in Pharmacology and related fields. He earned his Bachelor of Pharmacy (B.Pharm Hons) from Olabisi Onabanjo University, Ago-Iwoye, in 2014. Driven by his passion for advanced knowledge, he pursued a Master of Science (M.Sc) in Pharmacology, Therapeutics, and Toxicology at the University of Lagos, Akoka, completing the program in 2019. In addition to his pharmaceutical education, Dr. Oladoja has diversified his skill set by obtaining professional certifications. He became an Associate of the Institute of Chartered Accountants of Nigeria (ICAN) in 2018, enhancing his expertise in financial management. He also holds memberships in the Chartered Institute of Materials and Warehousing Management (ACIWM) and the Chartered Institute of Supply Chain Management (ACISM), further broadening his interdisciplinary knowledge. Currently, Dr. Oladoja is awaiting admission for his PhD in Pharmacology at the University of Lagos, Nigeria.

Professional Experience

Dr. Farouk Adedeji Oladoja has a solid foundation in Pharmacology and Toxicology, having served as a Lecturer at Olabisi Onabanjo University (OOU) since January 2021. With over two years of teaching experience, he has been actively involved in instructing undergraduate students in pharmacology across various programs, including Medicine, Nursing, and Pharmacy. His previous roles span clinical and community pharmacy positions, notably at HealthPlus Pharmacy, Olabisi Onabanjo University Teaching Hospital, and Mapic Pharmacy. In his current role, Dr. Oladoja teaches core pharmacology courses, supervises undergraduate projects, and contributes to curriculum development. His research interests include antidiabetic, antioxidant, and neuropharmacological studies, with a particular focus on African phytomedicine. He has authored numerous peer-reviewed papers and collaborated on projects ranging from toxicology studies to the phylogenetic analysis of SARS-CoV-2 variants in Nigeria. Dr. Oladoja’s academic and research contributions reflect his dedication to advancing pharmacological knowledge and practice.

Research Skills

Dr. Oladoja Farouk Adedeji possesses extensive research skills, particularly in pharmacology, toxicology, and natural products. His research expertise spans drug discovery, pharmacokinetics, pharmacodynamics, and the therapeutic properties of medicinal plants. Dr. Oladoja has conducted in-depth studies on the antidiabetic, antioxidant, and neuropharmacological properties of various plant extracts, contributing to scientific knowledge on alternative medicine and toxicology. His work also extends to toxicological assessments, having investigated the acute and sub-acute toxicity of herbal extracts. He is skilled in data collection, manuscript writing, and experimental design, as demonstrated in his numerous publications on plant-based treatments and toxicology. His involvement in advanced biochemical analysis, including antioxidant and anti-inflammatory assays, underscores his proficiency in laboratory techniques and research methodologies. Dr. Oladoja is committed to exploring the pharmacological potential of natural compounds, contributing significantly to the fields of pharmacology and toxicology.

Award and Recognition

Dr. Farouk Adedeji Oladoja has demonstrated excellence in pharmacology and toxicology, earning multiple awards and recognition throughout his career. Notably, he received the prestigious Distinguished Merit Award for Excellent Achievement in Sagamu for his contributions to community development. His academic prowess was acknowledged during his time at Olabisi Onabanjo University, where he was honored with the PANS OOU Excellence Award for being the Most Distinguished Student in 2013 and again in 2014. In 2021, Dr. Oladoja secured first place at the Annual General Meeting and Scientific Conference of the University of Lagos’ Faculty of Basic Medical Sciences for his outstanding poster presentation. These accolades reflect his dedication to research, education, and service, marking him as a leader in his field. His commitment to advancing pharmacology through research and teaching has earned him a well-deserved reputation for academic and professional excellence.

Conclusion

Dr. Oladoja has made significant contributions to the fields of pharmacology and toxicology within his short academic career. His innovative research, collaborative publications, and commitment to advancing African phytomedicine make him a strong contender for the Best Researcher Award. However, addressing his career advancement and seeking external funding would further solidify his position as an academic leader.

Publication Top Notes

  1. Title: Citrus aurantifolia (Chrism.) Swingle peel extract attenuate nephrotoxicity induced by doxorubicin
    Authors: Oyinloye, E.O.; Murtala, A.A.; Oladoja, F.A.; Kasumu, O.E.; Osipitan, L.E.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 11, Article ID: 100412
  2. Title: Cajanus cajan (L) Millsp seeds extract prevents rotenone-induced motor- and non-motor features of Parkinson disease in mice: Insight into mechanisms of neuroprotection
    Authors: Olubodun-Obadun, T.G.; Ishola, I.O.; Folarin, O.R.; Olopade, J.O.; Adeyemi, O.O.
    Year: 2024
    Journal: Journal of Ethnopharmacology
    Volume: 322, Article ID: 117623
  3. Title: Bambusa vulgaris attenuates Haloperidol-induced motor deficit and non-Motor co-morbidity in rats through up-regulation of Dopamine transmission and mitigation of pro-inflammatory cytokines activities
    Authors: Murtala, A.A.; Oladapo, O.E.; Oladoja, F.A.; Olaniran, E.O.; Osonuga, O.O.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 10, Article ID: 100375
  4. Title: Hypoglycemic, antidiabetic and toxicological evaluation of leaf extract of Xylopia parviflora (A. rich.) Benth
    Authors: Oladoja, F.A.; Irokosu, E.S.; Oyinloye, E.O.; Pender, G.C.; Popoola, O.A.
    Year: 2024
    Journal: Pharmacological Research – Modern Chinese Medicine
    Volume: 10, Article ID: 100358
  5. Title: Evaluation of Phytochemical constituents, Total Phenolic contents and in vitro Antioxidant Activities of Mucuna pruriens fractions leaves
    Authors: Elijah, O.O.; Murtala, A.A.; Oladoja, F.A.; Aderinola, A.A.; Kasumu, E.O.
    Year: 2023
    Journal: Journal of Phytomedicine and Therapeutics
    Volume: 22(1), pp. 1017–1034
  6. Title: Effects of glyphosate-based herbicide on gametes fertilization and four developmental stages in Clarias gariepinus
    Authors: Kale, O.E.; Adebesin, A.N.; Kale, T.F.; Wahab, M.; Ebele, C.C.
    Year: 2023
    Journal: Heliyon
    Volume: 9(4), e15048
  7. Title: Ethyl acetate fraction of Mucuna pruriens leaves mitigates diclofenac-induced hepatotoxicity via modulation of biochemical and histological parameters changes in Wistar Rats
    Authors: Oyinloye, O.; Murtala, A.; Oladoja, F.; Kasumu, E.; Iloka, P.
    Year: 2023
    Journal: Pharmacia
    Volume: 70(4), pp. 1201–1208
  8. Title: Alternative Medicine in Health Care: Is the Time not Now to Standardize African Phytomedicine to Indigenize Health Care and Create Entrepreneurial Opportunities?
    Authors: Adedeji, A.A.; Talabi, I.E.; Oladoja, F.
    Year: 2023
    Book: Medical Entrepreneurship: Trends and Prospects in the Digital Age, pp. 259–273
  9. Title: Antibiotic utilization study in a teaching hospital in Nigeria
    Authors: Sekoni, K.F.; Oreagba, I.A.; Oladoja, F.A.
    Year: 2022
    Journal: JAC-Antimicrobial Resistance
    Volume: 4(5), dlac093
  10. Title: Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity
    Authors: Akanji, M.A.; Elijah, O.O.; Oyedolapo, A.A.; Olatundun, S.O.; Edatomolaosi, O.L.
    Year: 2022
    Journal: Drug Metabolism and Personalized Therapy
    Volume: 37(3), pp. 305–314

 

Mohammad Hossein Boskabady | Pharmacology | Best Researcher Award

Dr. Mohammad Hossein Boskabady | Pharmacology | Best Researcher Award

Professor of Clinical Physiology, Mashhad University of Medical Sciences, Iran

Dr. Mohammad Hossein Boskabady is a distinguished researcher in the field of Pharmacology, renowned for his innovative contributions and groundbreaking research. With a strong background in pharmacological sciences, Dr. Boskabady’s work focuses on exploring the therapeutic potentials and mechanisms of various compounds. His extensive research has significantly advanced the understanding of drug actions and interactions, earning him recognition as a leading figure in pharmacological research. Dr. Boskabady’s commitment to scientific excellence and his impactful discoveries make him a deserving candidate for the Best Researcher Award.

Profile

Education 

Dr. Mohammad Hossein Boskabady’s academic journey began with his primary education in Boskabad, Khorasan, followed by high school in Gonabad, Khorasan, Iran. He earned his M.D. from Mashhad University of Medical Sciences. Dr. Boskabady furthered his studies as a postgraduate student in Physiology at University College London before completing his Ph.D. in Medicine at Charing Cross and Westminster Medical School, where he focused his thesis on the responsiveness of human bronchi to pharmacological agonists and antagonists. With a strong commitment to advancing pharmacological research, Dr. Boskabady aims to continue his research and lecturing at the university level, contributing to the field through innovative studies and academic excellence.

Employment

Dr. Mohammad Hossein Boskabady’s professional career began as a Doctor in the Emergency and Casualty Department at Imam Reza Hospital in Mashhad, Iran. Concurrently, he served as a Lecturer in Clinical Physiology at Ghaem Medical Centre, Mashhad University of Medical Sciences. Over the years, Dr. Boskabady advanced through academic ranks, holding positions as Assistant Professor, Associate Professor, and ultimately Professor in Clinical Physiology at the same institution. His extensive experience in both clinical practice and academic teaching underscores his significant contributions to the field of pharmacology and clinical physiology.

Awards

Dr. Mohammad Hossein Boskabady has been recognized for his outstanding contributions to research in Basic Medical Sciences with numerous prestigious awards. From 2000 to 2005, he won First Prizes at the Mashhad University of Medical Sciences Festival every year, and also received Second Prizes at the Razi National Festival in 2002 and 2006. He was honored as a Selected Researcher in Basic Medical Sciences for Khorasan Province in 2007 and 2008. Dr. Boskabady continued to excel, securing First Prizes at the Mashhad University of Medical Sciences Festival from 2009 to 2011, and was awarded Best Researcher at the same festival in 2012, 2013, 2016, and 2019. In 2021, he was recognized as a Selected Researcher at the School of Medicine, Mashhad University of Medical Sciences. Additionally, in November 2017, he was distinguished as a 1% world scientist by Essential Science Indicators (ESI), highlighting his global impact in the field

Official Posts

Dr. Mohammad Hossein Boskabady has held several significant roles throughout his career, reflecting his dedication and leadership in the field of medical sciences. From October 1994 to December 1996, he served as Consultant to the Vice Chancellor for Research at Mashhad University of Medical Sciences. He was a member of the Occupational Health Committee in Khorasan Province from November 1995 to October 1998 and also held the position of Director of International Affairs at Mashhad University of Medical Sciences from October 1996 to April 1999. Additionally, Dr. Boskabady was a member of the Scholarship Council from October 1997 to April 1999. He led the Physiology Department as Head from February 2000 to April 2002. Dr. Boskabady has been a member of the Editorial Board of the Journal of Basic Medical Sciences since October 1995 and has been involved with the Examination Board in Physiology for the Ministry of Health and Medical Education since August 2000. His other roles include serving on various research committees and councils at Mashhad University of Medical Sciences and acting as Secretary General for the 18th Congress of Iranian Physiology and Pharmacology in 2007. Since August 2011, he has been the Director of the Applied Biomedical Research Center at Mashhad University of Medical Sciences, and he has also served as Research Deputy for the School of Medicine from August 2011 to December 2013.

Publication Top Notes
  • Boskabady, M. H., & Snashall, P. D. (1992). Enhanced muscarinic receptor blockade with atropine in the asthmatic tracheobronchial tree: Evidence for increased drug delivery in asthma. American Review of Respiratory Disease, 145(5), 756-761. DOI: 10.1164/ajrccm/145.5.756.
  • Boskabady, M. H., & Snashall, P. D. (1996). Short term variation of atropine blockade in the tracheobronchial tree of asthmatic subjects. Medical Journal of the Islamic Republic of Iran, 10(3), 183-189. DOI: 10.17102/mjiri.1996.0108.
  • Boskabady, M. H., & Snashall, P. D. (1997). Enhanced histamine H1 receptor blockade with chlorpheniramine in the asthmatic tracheobronchial tree: Further evidence for increased drug delivery in asthma. Medical Journal of the Islamic Republic of Iran, 11(2), 115-122. DOI: 10.17102/mjiri.1997.0063.
  • Boskabady, M. H., & Shhabi, M. (1997). Bronchodilatory and anticholinergic effects of Nigella sativa on isolated guinea pig tracheal chains. Iranian Journal of Medical Sciences, 22(4), 127-133. DOI: 10.30476/ijms.1997.0549.
  • Boskabady, M. H., Rakhshandah, H., & Moetamedshariati, V. (1998). Bronchodilatory and anticholinergic effects of Carum copticum on isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 11(5), 329-334. DOI: 10.17102/mjiri.1998.0134.
  • Boskabady, M. H., & Harati, M. (1998). Increased histamine H1 receptor blockade by chlorpheniramine in tracheal chains of asthmatic guinea-pigs. Medical Journal of the Islamic Republic of Iran, 12(2), 265-271. DOI: 10.17102/mjiri.1998.0089.
  • Boskabady, M. H., & Talebi, M. (1999). Bronchodilatory and anticholinergic effects of Carum carvi on isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 12(3), 345-351. DOI: 10.17102/mjiri.1999.0154.
  • Boskabady, M. H., & Adel-Kardan, S. (1999). Increased muscarinic receptor blockade by atropine in tracheal chains of ovalbumin-sensitized guinea-pigs. Pharmacology, 58(6), 300-308. DOI: 10.1159/000029652.
  • Boskabady, M. H., & Shikhi, J. (2000). Inhibitory effect of Carum copticum on histamine (H1) receptors of isolated guinea pig tracheal chains. Journal of Ethnopharmacology, 69(2), 217-227. DOI: 10.1016/S0378-8741(99)00244-3.
  • Boskabady, M. H., & Simaei, N. (1999). Prevalence of asthma among young adults (high school students) in the city of Mashhad (north east of Iran). Iranian Journal of Medical Sciences, 24(1), 48-52. DOI: 10.30476/ijms.1999.0442.
  • Boskabady, M. H., & Snashall, P. D. (2000). Bronchial responsiveness to beta-adrenergic stimulation and enhanced beta blockade in asthma. Respirology, 5(2), 111-118. DOI: 10.1046/j.1440-1843.2000.00243.x.
  • Boskabady, M. H., & Moemeni, A. (2000). Stimulatory effect of Carum copticum on beta2 adrenoceptors of isolated guinea pig tracheal chains. Medical Journal of the Islamic Republic of Iran, 13(3), 273-278. DOI: 10.17102/mjiri.2000.0192.
  • Boskabady, M. H., Karbandy, S., & Abedinzadah, A. (2000). The effects of arterial O2 saturation and heart rate on blood pressure. Medical Journal of the Islamic Republic of Iran, 14(2), 37-41. DOI: 10.17102/mjiri.2000.0200.
  • Boskabady, M. H., & Karimian, M. (2000). Prevalence of asthma among guidance school students (aged 11-16 years) in the city of Mashhad (north east of Iran). Archives of Iranian Medicine, 3(3), 165-169. DOI: 10.30476/aim.2000.0109.
  • Boskabady, M. H., & Hosaini, M. (2000). Effect of patient education and regular PEF measurement on self-management of asthma. Iranian Journal of Allergy, Asthma, and Immunology, 1(2), 159-164. DOI: 10.30476/ijaai.2000.0111.
  • Boskabady, M. H., & Ramazani, M. (2001). Relaxant effect of Pimpinella anisum on isolated guinea pig tracheal chains and its possible mechanism(s). Journal of Ethnopharmacology, 74(1), 83-88. DOI: 10.1016/S0378-8741(00)00382-5.
  • Boskabady, M. H., Keshmiri, M., Banihashemi, B., & Anvary, K. H. (2002). Lung function values in healthy non-smoking urban adults in Iran. Respiration, 69(4), 320-326. DOI: 10.1159/000065155.
  • Boskabady, M. H., & Klahdoz, G. H. (2002). Prevalence of asthma symptoms among the adult population in the city of Mashhad (north-east of Iran). Respirology, 7(3), 267-272. DOI: 10.1046/j.1440-1843.2002.00413.x.
  • Boskabady, M. H., & Shirmohammadi, B. (2002). Effect of Nigella sativa on isolated guinea pig trachea. Archives of Iranian Medicine, 5(2), 103-107. DOI: 10.30476/aim.2002.0145.
  • Boskabady, M. H., & Shiravi, N. (2002). Inhibitory effect of Nigella sativa on histamine (H1) receptors of isolated guinea pig tracheal chains. Pharmaceutical Biology, 40(8), 596-602. DOI: 10.1076/1388-0209(200208)4008-0005.